Akero Therapeutics, Inc. Loans Payable, Noncurrent
Akero Therapeutics, Inc. had Loans Payable, Noncurrent of $22.16 million as of 2025-06-30, per its 10-Q filed 2025-08-08.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Noncurrent
us-gaap:LongTermLoansPayable · last filed 2025-11-07
- 2025-06-30: Loans Payable, Noncurrent $22.16M.
- 2025-03-31: Loans Payable, Noncurrent $28.81M.
- 2024-12-31: Loans Payable, Noncurrent $35.30M.
- 2024-09-30: Loans Payable, Noncurrent $35.12M.
| Period end | Loans Payable, Noncurrent |
|---|---|
| 2025-06-30 | $22.16M 10-Q · filed 2025-08-08 |
| 2025-03-31 | $28.81M 10-Q · filed 2025-05-12 |
| 2024-12-31 | $35.30M 10-Q · filed 2025-11-07 |
| 2024-09-30 | $35.12M 10-Q · filed 2024-11-08 |
| 2024-06-30 | $34.96M 10-Q · filed 2024-08-09 |
| 2024-03-31 | $34.80M 10-Q · filed 2024-05-10 |
| 2023-12-31 | $24.96M 10-K · filed 2025-02-28 |
| 2023-09-30 | $22.77M 10-Q · filed 2023-11-13 |
| 2023-06-30 | $24.73M 10-Q · filed 2023-08-11 |
| 2023-03-31 | $24.62M 10-Q · filed 2023-05-15 |
| 2022-12-31 | $9.54M 10-K · filed 2024-02-29 |
| 2022-09-30 | $9.45M 10-Q · filed 2022-11-04 |
| 2022-06-30 | $9.37M 10-Q · filed 2022-08-05 |